Brokers Offer Predictions for ELEKTA AB/ADR’s FY2019 Earnings (EKTAY)

ELEKTA AB/ADR (OTCMKTS:EKTAY) – Stock analysts at Jefferies Financial Group issued their FY2019 EPS estimates for shares of ELEKTA AB/ADR in a note issued to investors on Tuesday, December 4th. Jefferies Financial Group analyst K. Lee anticipates that the company will post earnings per share of $0.39 for the year. Jefferies Financial Group also issued estimates for ELEKTA AB/ADR’s FY2020 earnings at $0.45 EPS, FY2021 earnings at $0.51 EPS and FY2022 earnings at $0.57 EPS.

Several other equities research analysts also recently commented on the stock. Zacks Investment Research downgraded shares of ELEKTA AB/ADR from a “buy” rating to a “hold” rating in a report on Tuesday, August 14th. UBS Group raised shares of ELEKTA AB/ADR from a “neutral” rating to a “buy” rating in a report on Wednesday, November 28th.

OTCMKTS EKTAY opened at $12.15 on Thursday. The stock has a market cap of $4.41 billion, a price-to-earnings ratio of 34.71 and a beta of 0.43. ELEKTA AB/ADR has a 52 week low of $7.85 and a 52 week high of $14.61. The company has a current ratio of 1.14, a quick ratio of 0.89 and a debt-to-equity ratio of 0.63.


Elekta AB (publ) provides equipment and software for cancer and brain disorders worldwide. The company offers radiotherapy systems under the Versa HD, Precise Treatment System, and Elekta Compact names; Elekta Infinity, an image-guided radiation therapy (IGRT) system; and Elekta Synergy, a digital accelerator for advanced IGRT.

See Also: What is a balanced fund?

Receive News & Ratings for ELEKTA AB/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ELEKTA AB/ADR and related companies with's FREE daily email newsletter.

Leave a Reply